Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.34203.06-34.5980.29-16.93

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 9.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.34
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2025 9.34
-95.40
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹888.7 Cr -1% -0.4% 11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.1% 1.9% -8.5% Stock Analytics
DIVIS LABORATORIES ₹182,810.0 Cr 3.5% 18.2% 15.4% Stock Analytics
CIPLA ₹121,170.0 Cr -2.6% -0.9% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,300.0 Cr -1.3% 0.8% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr 0.2% -3.5% -5.8% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

-1%

-0.4%

11.6%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses